|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used in) operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Accretion of asset retirement obligations | |||||
| Depreciation, depletion, and amortization | |||||
| Amortization of debt issuance costs | |||||
| Stock-based compensation | |||||
| (Gain)/loss on disposal of assets | |||||
| Other income - gain on insurance recoveries | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventories | |||||
| Other assets and liabilities | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Net cash from operating activities | |||||
| Cash flows from (used in) investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of assets | |||||
| Amonate Asset Acquisition | |||||
| Land and mineral acquisition | |||||
| Acquisition of Maben assets (bond recovery in 2023) | |||||
| Maben Asset Acquisition | |||||
| Total acquisition of Maben assets (bond recovery in 2023) | |||||
| Proceeds from sale of mineral rights | |||||
| Insurance proceeds related to property, plant, and equipment | |||||
| Maben preparation plant capital expenditures | |||||
| Capitalized interest | |||||
| Payments to Acquire Property, Plant, and Equipment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from (used in) financing activities: | |||||
| Proceeds from issuance of senior note debt (net of $2,340 commissions and fees) | |||||
| Proceeds from equity offering | |||||
| Payment of equity offering costs | |||||
| Proceeds from long-term debt issuances | |||||
| Purchase of capped calls | |||||
| Proceeds from borrowings | |||||
| Repayment of borrowings | |||||
| Repayments of senior notes | |||||
| Repayment of Ramaco Coal acquisition financing - related party | |||||
| Proceeds from stock options exercised | |||||
| Payment of dividends | |||||
| Repayments of insurance financing | |||||
| Repayments of equipment finance leases | |||||
| Payment of debt issuance costs | |||||
| Shares surrendered for withholding taxes payable | |||||
| Net cash from (used in) financing activities | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest (net of amounts capitalized) | |||||
| Cash paid for income taxes | |||||
| Cash received for income tax refund | |||||
| Non-cash investing and financing activities: | |||||
| Leased assets under financing leases | |||||
| Capital expenditures included in accounts payable and accrued liabilities | |||||
| Financed insurance | |||||
| Financed insurance (2022 adjustment recorded in 2023) | |||||
| Accrued dividends and dividend equivalents payable | |||||
Loading...